[Peripheral benzodiazepine receptor agonist Ro5-4864 inhibits mitochondrial permeability transition in rat heart]

Jing-Yuan Li1, Jun-Ke Wang, Yin-Ming Zeng

  • 1Department of Anesthesiology, the First Affiliated Hospital, China Medical University, Shenyang 110001, China.

Insights

Activation of the peripheral benzodiazepine receptor (PBR) with Ro5-4864 prevents mitochondrial injury by inhibiting MPT pore opening during calcium overload. This PBR activation preserves mitochondrial function and may offer cardioprotection.

Area of Science:

  • Mitochondrial Physiology
  • Cardiovascular Research
  • Pharmacology

Background:

  • Mitochondrial permeability transition (MPT) pore opening causes mitochondrial injury during oxidative stress.
  • The peripheral benzodiazepine receptor (PBR) is located on the outer mitochondrial membrane and influences mitochondrial functions.

Purpose of the Study:

  • To investigate if peripheral benzodiazepine receptor (PBR) activation by Ro5-4864 can prevent MPT pore opening during calcium overloading.
  • To assess the protective effects of PBR activation on mitochondrial integrity and function.

Main Methods:

  • Cardiac mitochondria were isolated from Sprague-Dawley rats and subjected to calcium (Ca2+) overload to induce MPT.
  • Ro5-4864, a PBR agonist, was added to assess its effect on MPT pore opening, monitored by absorbance changes.
  • Western blot was used to detect cytochrome C release, and mitochondrial membrane potential was assessed using JC-1 dye.

Main Results:

  • Ro5-4864 significantly inhibited MPT pore opening induced by Ca2+.
  • PBR activation preserved mitochondrial cytochrome C content and maintained mitochondrial membrane potential.
  • The protective effect of Ro5-4864 was abolished by atractyloside (ATR), an MPT pore opener.

Conclusions:

  • Activation of peripheral benzodiazepine receptor (PBR) prevents mitochondrial permeability transition (MPT) pore opening during calcium overload.
  • PBR activation maintains mitochondrial cytochrome C content and membrane potential, suggesting a cardioprotective role.
  • Targeting PBR may represent a novel therapeutic strategy for conditions involving cardiac ischemia and reperfusion injury.

Related Concept Videos